Skip to content

Zentalis Pharmaceuticals, Inc.

ZNTL

CIK 0001725160 · Pharmaceutical Preparations · Nasdaq

  • Zentalis Pharmaceuticals, LLC (until 2020-04-06)
  • Zeno Pharma, LLC (until 2019-09-05)
← back to feed
Revenue (TTM)
$0
−100.0% YoY Q1 May 2026
Net Income (TTM)
−$137.2M
+17.4% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.91
+18.0% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$166.92M
Q1 May 2026
Cash
$31.93M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
71.19M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings